Back to search
Pleura Mesothelioma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pleura Mesothelioma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pleura Mesothelioma trials you may qualify forParticipants will receive sacituzumab govitecan until their disease gets worse (progresses), they have severe side effects and cannot continue study treatment,…
This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.
Malignant pleural mesothelioma (MPM) is a rare and incurable cancer. Most patients are diagnosed with unresectable disease for which treatment options are limit…
Background: * Chromatin is is the structural building block of a chromosome. It is found inside the nucleus of the cell and consists of a complex of DNA and pr…
This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of Volrustomig (MEDI5752) + Carboplatin + Pemetrexed…
The researchers are doing this study to test the safety of BMS-986504 in combination with standard disease-specific anticancer medication in people with metasta…
This phase II trial studies how well pembrolizumab works in treating patients with malignant mesothelioma, a cancer of the linings around the lungs (pleura) or…
To test the safety of and effectiveness of XmAb20717 for participants with advanced rare cancers.
This phase I pilot trial studies how well atezolizumab, pemetrexed disodium, cisplatin, and surgery with or without radiation therapy works in treating patients…